[1] GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 [J]. Lancet Neurol, 2019, 18(1): 56-87.
[2] Jiang J Y, Gao G Y, Feng J F, et al. Traumatic brain injury in China [J]. Lancet Neurol, 2019, 18(3): 286-295.
[3] Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury [J]. J Neurotrauma, 2007, 24 (Suppl 1): S1-106.
[4] Shigemori M, Abe T, Aruga T, et al. Guidelines for the management of severe head injury, 2nd Edition guidelines from the guidelines committee on the management of severe head injury, the Japan society of neurotraumatology [J]. Neurol Med Chir (Tokyo), 2012, 52(1): 1-30.
[5] Barbosa R R, Jawa R, Watters J M, et al. Evaluation and management of mild traumatic brain injury: an eastern association for the surgery of trauma practice management guideline [J]. J Trauma Acute Care Surg, 2012, 73(5 Suppl 4): S307-314.
[6] Carney N, Totten A M, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury, Fourth Edition [J]. Neurosurgery, 2017, 80(1): 6-15.
[7] Lumba-Brown A, Yeates K O, Sarmiento K, et al. Centers for Disease Control and prevention guideline on the diagnosis and management of mild traumatic brain injury among children [J]. JAMA Pediatr, 2018, 172(11): e182853.
[8] 中国医师协会神经外科医师分会, 中国神经创伤专家委员会. 中国颅脑创伤病人脑保护药物治疗指南 [J]. 中华神经外科杂志, 2008, 24(10): 723-724.
[9] 中国医师协会神经外科医师分会, 中国神经创伤专家委员会. 中国颅脑创伤外科手术指南 [J]. 中华神经外科杂志, 2009, 25(2): 100-101.
[10] 中国神经外科医师协会神经创伤专家委员会, 中华医学会创伤学分会神经创伤专业学组. 神经外科危重昏迷患者肠内营养专家共识 [J]. 中华创伤杂志, 2010, 26(12): 1057-1059.
[11] 中国医师协会神经外科医师分会, 中国神经创伤专家委员会. 中国颅脑创伤颅内压监测专家共识 [J]. 中华神经外科杂志, 2011, 27(10): 1073-1074.
[12] 中华神经外科学会神经创伤专业组. 颅脑创伤去骨瓣减压术中国专家共识[J]. 中华神经外科杂志, 2013, 29(9): 967-969.
[13] 中华医学会神经外科学分会颅脑创伤专业组, 中华医学会创伤学分会神经损伤专业组. 颅脑创伤长期昏迷诊治中国专家共识 [J]. 中华神经外科杂志, 2015, 31(8): 757-760.
[14] Bruenig D, Mehta D, Morris C P, et al. Fluid biomarkers for mild traumatic brain injury and related conditions [J]. Nat Rev Neurol, 2016, 12(10): 563-574.
[15] Devic I, Hwang H, Edgar J S, et al. Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease [J]. Brain, 2011, 134(Pt 7): e178.
[16] Rodríguez-Rodríguez A, Egea-Guerrero J J, Gordillo-Escobar E, et al. S100B and Neuron-Specific Enolase as mortality predictors in patients with severe traumatic brain injury [J]. Neurol Res, 2016, 38(2): 130-137.
[17] Czeiter E, Mondello S, Kovacs N, et al. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator [J]. J Neurotrauma, 2012, 29(9): 1770-1778.
[18] Yan E B, Satgunaseelan L, Paul E, et al. Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury [J]. J Neurotrauma, 2014, 31(7): 618-629.
[19] Bogoslovsky T, Wilson D, Chen Y, et al. Increases of plasma levels of glial fibrillary acidic protein, Tau, and amyloid β up to 90 days after traumatic brain injury [J]. J Neurotrauma, 2017, 34(1): 66-73.
[20] Dendrou C A, McVean G, Fugger L, et al. Neuroinflammation - using big data to inform clinical practice [J]. Nat Rev Neurol, 2016, 12(12): 685-698.
[21] Kearney C J, Martin S J. An Inflammatory Perspective on Necroptosis [J]. Mol Cell, 2017, 65(6): 965-973.
[22] Wang Y Q, Wang L, Zhang M Y, et al. Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model [J]. Neurochem Res, 2012, 37(9): 1849-1858.
[23] Hosp F, Mann M. A primer on concepts and applications of proteomics in neuroscience [J]. Neuron, 2017, 96(3): 558-571.
[24] Sowers J L, Wu P, Zhang K, et al. Proteomic changes in traumatic brain injury: experimental approaches [J]. Curr Opin Neurol, 2018, 31(6): 709-717.